![Left to right, Eben Lichtman, MD, and Gianpietro Dotti, MD, have identified a potential way to use CAR T-cells to target a subtype of acute myeloid leukemia.](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2020/06/researchers-identify-experimental-immunotherapy-approach-to-target-acute-myeloid-leukemia-image2.jpeg)
January 3, 2019
Researchers identify experimental immunotherapy approach to target acute myeloid leukemia
At the 60th American Society of Hematology Annual Meeting in San Diego on Dec. 3, Eben Lichtman, MD, presented preliminary findings from preclinical studies of CAR T-cells directed towards a potential target called B7-H3, which is found on the cell surface of certain types of AML.